Renal osteodystrophy in rats with reduced renal mass

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 3, 1996, Pages 146-152

  Moscovici, A ^a   Bernheim, J ^b   Popovtzer, M M ^a   Rubinger, D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Calcitriol; Renal failure; Renal osteodystrophy; Secondary hyperparathyroidism

Indexed keywords

CALCITRIOL; CREATININE; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; HISTOMETRY; KIDNEY FAILURE; KIDNEY MASS; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; RAT; RENAL OSTEODYSTROPHY; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA;

EID: 0029739340     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp3.146     Document Type: Conference Paper

References (36)

1. Nomura T, Katsuki M, Yokoyama M, Tajima Y. Future perspectives in the development of new animal models, Prog Clin Biol Res 1987; 229: 337-353
2. Sherrard DJ, Herz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 1993; 43: 436-442
3. Massry SG. Divalent in metabolism and renal osteodystrophy. In: Massry and Glassock's Textbook of Nephrology, 3rd edn. Baltimore: Williams & Wilkins, 1995; 77: 1441-1473
4. Hruska AK, Teitelbaum SL. Renal osteodystrophy. New Engl J Med 1995; 333: 166-174
5. Kraft K, Brassotti G, Gionanetti S, Wetzel E, Gretz N, Strauch M. Renal bone disease in chronic uremic rats. Contrib Nephrol 1986; 60: 214-219
6. Kimmel D, Ritz E, Krempien B, Mehls O. Bone cell kinetics and function during experimental uremia. Metab Bone Dis Rel Res 1981; 3: 191-198
7. Chagnac A, Gazit D, Zahavi I, Sela J, Levi J. Effect of verapamil on bone resorption and formation in uremic rats. Miner Electrolyte Metab 1989; 15: 291-294
8. Hirschel-Scholz S, Charhon S, Rizzoli R, Caverzasio J, Paunier L, Bonjour JP. Protection from progressive renal failure and hyperparathyroid bone remodelling by WR 2721. Kidney Int 1988; 33: 934-941
9. Nishii Y, Ono M, Fukishima M et al. Osseous changes and abnormalities of mineral metabolism in rats with glycopeptideinduced nephritis. Endocrinology 1980; 107: 319-327
10. Kaspareit-Rittinghausen J, Rapp K, Deerberg F, Weislo A, Messow C. Hereditary polycystic disease associated with osteorenal syndrome in rats. Vet Pathol 1989; 26: 195-201
11. Gagnon RF, Gallimore B. Characterization of a mouse model of chronic uremia. Urol Res 1988; 16: 119-126
12. Nordin RW, Shih MS. Profiles of cortical remodeling sites in longitudinal rib sections of beagles with renal failure and parathyroid hyperplasia. Metab Bone Dis Relat Res 1983; 4: 353-359
13. Kalu DN, Masoro E-J, Yu BP, Hardin RR, Hollis BH. Modulation of age related hyperparathyroidism and senile bone loss in Fisher rats by soy protein and food restriction. Endocrinology 1988; 122: 1847-1854
14. Orwoll ES. The effects of dietary protein insufficiency and excess on skeletal health. Bone 1992; 13: 349-350
15. Lieuallen WG, Weisbrode SE, Horst RL. The effects of the major vitamin D metabolites upon the resolution of osteomalacia in uremic adult rats. Bone 1990; 11: 267-273
16. Ittel TH, Gruber E, Heinrichs A. Handt S, Hofstaedter F, Siebert HG. Effect of fluoride on aluminum induced bone disease in rats with renal failure. Kidney Int 1992; 41: 1340-1348
17. Lieuallen WG, Weisbrode SE. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats. J Bone Min Res 1991; 6: 751-757
18. 3) in mild subacute uremia. In: Vitamin D, Chemical, Biochemical and Clinical Update. Berlin: Walter de Gruyter & Co, 1985; 465-468
19. Rodriguez M, Lorenzi V, Felsenfeld AJ, Llach F. Effect of parathyroidectomy on aluminum toxicity and azotemic bone disease in the rat. J Bone Min Res 1990; 5: 379-386
20. Felsenfeld AJ, Machaldo L, Rodriguez M. The effect of high parathyroid hormone levels on the development of aluminuminduced osteomalacia in the rat. Am J Soc Nephrol 1991; 1: 970-979
21. Gazit D, Ehrlich J, Kohen Y, Bab I. Effect of occlusal (mechanical) stimulus on bone remodeling in rat mandibular condyle. J Oral Pathol 1987; 16: 395-398
22. Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 1987; 2: 595-610
23. Frost HM, Jee WSS. On the rat model of human osteopenias and osteoporoses. Bone Mineral 1992; 18: 227-236
24. Pritchard JJ. General histology of bone. In: Bourne GH, ed. The Biochemistry and Physiology of Bone Vol. 1, 2nd edn. New York: Academic Press, 1972.
25. Malluche H, Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211
26. 3 and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-1077
27. Malluche HH, Ritz E, Lange H et al. Bone histology in incipient and advanced renal failure. Kidney Int 1976; 9: 355-362
28. Cobrun JW, Slatopolsky E. Vitamin D, parathyroid hormone and the renal osteodystrophies. In: Brenner BM, Rector FC Jr, eds. The Kidney, 45th edn. Philadelphia: WB Saunders, 1991; 2036-2120
29. Hercz G, Pei Y, Greenwood C et al. Aplastic osteodystrophy without aluminum: the role of 'suppressed' parathyroid function. Kidney Int 1993; 44: 860-866
30. Coburn JW. Mineral metabolism and renal bone disease. Effects of CAPD versus hemodialysis. Kidney Int 1993; 40(Suppl): S92-S100
31. Andress DL, Hercz G, Kopp JB et al. Bone histomorphometry of renal osteodystrophy in diabetic patients. J Bone Miner Res 1987; 2: 525-531
32. Goodman WG, Ramirez JA, Berlin TR et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 1994; 46: 1160-1166
33. Rodan JA. Introduction to bone histology. Bone 1992; 13: 53-56
34. Chow JWM, Badne S, Chambers TJ. A comparison of microanatomic basis for coupling between bone formation and bone resorption in man and in rat. Bone 1994; 14: 355-360
35. Slatopolsky E, Weerts C, Thielan J, Horst RL, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism of intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143
36. Moscovici A, Gafter U, Popovtzer MM. Calcitriol pulse therapy arrests bone formation in dialysis patients with refractory secondary hyperparathyroidism (2-HPTH). Abstract, 27th Annual Meeting American Society of Nephrology, Orlando, Florida, 26-29 October 1994